Remimazolam sedation for cataract surgery
Treatments studied
Part of Mental health clinical trials.
This study tests a sedative, remimazolam, for older adults having their first cataract surgery. It aims to see if it helps keep patients comfortable and calm without needing general anesthesia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years or older.
- You are having your first cataract surgery with numbing eye drops only.
- You are in generally good health or have conditions like high blood pressure or diabetes that are stable (ASA class 2, 3, or 4).
- You can understand simple English instructions and cooperate with a thinking-and-memory test.
- You do not have moderate or severe sleep apnea, and you are not taking strong painkillers (opioids) for chronic pain.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a sedative called Remimazolam for people having cataract surgery on both eyes. The goal is to see if it works well and safely for short procedures.
This trial compares two sedatives, remimazolam and midazolam, to see which one leads to better recovery of thinking skills after orthopedic surgery. It is for people aged 65 and older who are having surgery on a bone or joint while awake but relaxed.
This trial tests a sedative called remimazolam besylate in patients who need a breathing tube and light sedation after non-cardiac surgery. The goal is to see if it works well and is safe.
This study compares two sedative medicines used to start general anesthesia in patients 65 and older having non-cardiac surgery. The goal is to see which one is safer and works better for older patients.
This trial tests if a sedative called remimazolam can reduce confusion or delirium in older adults after laparoscopic stomach surgery. If you are at least 65 years old and scheduled for this surgery, you may be eligible.
This study uses brain scans to see how a new sedative called remimazolam affects the brain in healthy adults. It will help researchers understand the drug's effects and ensure it's safe.
Hear when a new Cataract Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.